F. I. Khamrabaeva

5 ta ish

Tashkent Pediatric Medical Institute

1. Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease

   M. Yu. Nadinskaia, М. V. Maevskaya, В. Т. Ивашкин +9

   MaqolaOAOchiq kirishLiver Disease Diagnosis and TreatmentWorld Journal of Gastroenterology20211 iqtibos

   ABIABI:AkademIndex/2021.article.000032

2. Biomarkers of Liver in Patients with Chronic Pancreatitis Associated with Metabolic Syndrome

   Gulchehra R. Yuldasheva, F. I. Khamrabaeva, A. A. Khadzhimetov

   MaqolaOAOchiq kirishPancreatitis Pathology and TreatmentDOAJ (DOAJ: Directory of Open Access Journals)20140 iqtibos

   ABIABI:AkademIndex/2014.article.000700

3. The diseases of the upper part of gastrointestinal tract: risk factors

   F. I. Khamrabaeva

   MaqolaOAOchiq kirishHealthcare Systems and Public HealthModern Gastroenterology20180 iqtibos

   ABIABI:AkademIndex/2018.article.001035

4. FEATURES OF THE BLOOD LEPTIN INDEX IN PATIENTS WITH CHRONIC PANCREATITIS ASSOCIATED WITH INSULIN RESISTANCE

   G.R. Yuldasheva, F. I. Khamrabaeva

   MaqolaPancreatitis Pathology and TreatmentEuropean Science Review20190 iqtibos

   ABIABI:AkademIndex/2019.article.001903

5. Treatment of gastroesophageal reflux disease with autonomic dystonia syndrome with combination of proton pump inhibitor Rabeprazole and neuroleptic sulpiride

   F. I. Khamrabaeva

   MaqolaOAOchiq kirishGastroesophageal reflux and treatmentsExperimental and Clinical Gastroenterology20200 iqtibos

   ABIABI:AkademIndex/2020.article.003255